Characterisation of lymphocyte responses to Ca2+ in Scott syndrome

Thrombosis and Haemostasis

Volumn 91, Issue 2, 2004, Pages 412-415

  Elliott, James I ^a   Mumford, Andrew D ^b   Albrecht, Christiane ^b   Collins, Peter W ^b   Giddings, John C ^b   Higgins, Christopher F ^b   Tuddenham, Edward G D ^b   McVey, John H ^b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CALCIUM IONOPHORE; LIPOCORTIN 5; PROTHROMBIN;

ADULT; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; BLEEDING TIME; BLOOD CLOTTING TEST; CALCIUM TRANSPORT; CASE REPORT; CELL MEMBRANE PERMEABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LETTER; PRIORITY JOURNAL; SCOTT SYNDROME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

EID: 1242306901     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613744     Document Type: Letter

References (12)

1. Weiss HJ, Vicic WJ, Lages BA, et al.. Isolated deficiency of platelet procoagulant activity. Am J Med 1979; 67: 206-13.
2. Gilbert GE, Arena AA. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem 1996; 271: 11120-5.
3. Toti F, Satta N, Fressinaud E, et al.. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996; 87: 1409-15.
4. Weiss HJ, Lages B. Family studies in Scott syndrome. Blood 1997; 87: 475-6.
5. Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998; 92: 1707-12.
6. 2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest 1997; 99: 2232-8.
7. 2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry 1999; 38: 10092-8.
8. Munnix IC, Harmsma M, Giddings JC, et al.. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003; 89: 687-95.
9. Parry DH, Giddings JC, Bloom AL. Familial haemostatic defect associated with reduced prothrombin consumption. Br J Haematol 1980; 44: 323-34.
10. Kojima H, Newton-Nash D, Weiss HJ, et al.. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 1994; 94: 2237-44.
11. Elliott JI, Higgins CF. IKCa1 activity is required for cell shrinkage, phosphatidylserine translocation and death in T lymphocyte apoptosis. EMBO Reports 2002; 4: 189-94.
12. Sims PJ, Wiedmer T, Esmon CT, et al.. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.